Position
Squarepoint Ops LLC in Sagimet Biosciences Inc.
Back to the book · All holders of SGMT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$58.9K$5.92 → $5.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 84.7K | $501.6K | — | — | — | 0.0% |
| Q1 2026 | 118.6K | $619.8K | $5.23 | −$58.9K | $177.1K | 0.0% |